Literature DB >> 9402544

Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period.

E M Hoogerwaard1, W G de Voogt, A A Wilde, P A van der Wouw, E Bakker, G J van Ommen, M de Visser.   

Abstract

We evaluated the course of cardiac involvement in 27 previously reported patients with Becker muscular dystrophy (BMD) originating from nine kindreds. Since almost all affected individuals of each kindred were included, intrafamilial variability could be studied. We also attempted to identify associations between cardiac involvement, functional ability and mutations at DNA level. The mean follow-up period was 12.5 years. The number of patients with electrocardiographic abnormalities progressed from 44% to 71%. Dilated cardiomyopathy (DCM) with or without congestive heart failure was now present in 33% as compared with 15% in the previous study. In addition, 22% developed borderline echocardiographic abnormalities. Six patients (22%) became symptomatic and four patients died of congestive heart failure. In all families cardiac abnormalities were found. There was no association between DCM and mutation type. Despite equal functional motor ability, there was a considerable intrafamilial variation in cardiac involvement, even in brother pairs. We conclude that cardiac abnormalities are the rule and not the exception in BMD and are progressive over time. Left ventricular dilatation may begin at any moment in the course of BMD and the rate of progression is unpredictable. A substantial proportion of patients will develop an incapacitating and life-threatening DCM.

Entities:  

Mesh:

Year:  1997        PMID: 9402544     DOI: 10.1007/s004150050163

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy.

Authors:  A Varghese; D J Pennell
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

2.  rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart.

Authors:  Rui Xu; Ying Jia; Deborah A Zygmunt; Paul T Martin
Journal:  Mol Ther       Date:  2019-01-15       Impact factor: 11.454

3.  A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy.

Authors:  E A Burton; J M Tinsley; P J Holzfeind; N R Rodrigues; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 4.  [Cardiac manifestations of muscular dystrophies].

Authors:  A Perrot; S Spuler; C Geier; R Dietz; K J Osterziel
Journal:  Z Kardiol       Date:  2005-05

Review 5.  Cardiac involvement in Duchenne and Becker muscular dystrophy.

Authors:  Sophie Mavrogeni; George Markousis-Mavrogenis; Antigoni Papavasiliou; Genovefa Kolovou
Journal:  World J Cardiol       Date:  2015-07-26

6.  Severe cardiomyopathy in mice lacking dystrophin and MyoD.

Authors:  L A Megeney; B Kablar; R L Perry; C Ying; L May; M A Rudnicki
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

Review 7.  Cardiac involvement in Becker muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

8.  Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers.

Authors:  Natee Jearawiriyapaisarn; Hong M Moulton; Peter Sazani; Ryszard Kole; Monte S Willis
Journal:  Cardiovasc Res       Date:  2009-10-08       Impact factor: 10.787

Review 9.  Usefulness of heart rate variability as a predictor of sudden cardiac death in muscular dystrophies.

Authors:  L Politano; A Palladino; G Nigro; M Scutifero; V Cozza
Journal:  Acta Myol       Date:  2008-12

10.  Improved Cardiac Outcomes by Early Treatment with Angiotensin-Converting Enzyme Inhibitors in Becker Muscular Dystrophy.

Authors:  Caroline Stalens; Leslie Motté; Anthony Béhin; Rabah Ben Yaou; France Leturcq; Guillaume Bassez; Pascal Laforêt; Bertrand Fontaine; Stéphane Ederhy; Marion Masingue; Malika Saadi; Sarah Leonard Louis; Nawal Berber; Tanya Stojkovic; Denis Duboc; Karim Wahbi
Journal:  J Neuromuscul Dis       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.